Sunshine Biopharma Inc. (SBFM) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$348.3K2011: -$297.3K2012: -$393.1K2013: -$564.4K2014: -$538.6K2015: -$867.6K2016: -$314.2K2017: -$543.5K2018: -$512.8K2019: -$495.8K2020: -$657.3K2021: -$1.83M2022: -$5.25M2023: -$8.78M2024: -$12.52M2025: -$5.33M-$5.33M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$5.33M+57.4%
2024-$12.52M-42.7%
2023-$8.78M-67.2%
2022-$5.25M-186.9%
2021-$1.83M-178.3%
2020-$657.3K-32.6%
2019-$495.8K+3.3%
2018-$512.8K+5.7%
2017-$543.5K-73.0%
2016-$314.2K+63.8%
2015-$867.6K-61.1%
2014-$538.6K+4.6%
2013-$564.4K-43.6%
2012-$393.1K-32.2%
2011-$297.3K+14.6%
2010-$348.3K